AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease
AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease
Recruiting · NCT07182422 · Registry updated 2025-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2025-09-19 | NCT07182422 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chang Gung Memorial Hospital | 214 |
| Conmed Pharmaceutical & Bio-Medical Corporation | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital, Taoyuan, Taiwan | Taoyuan | Taiwan | 1 |